VNDA icon

Vanda Pharmaceuticals
VNDA

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$21
200% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Truist Securities
Truist Securities
Les Sulewski
100% 1-yr VNDA win rate
5 Mar ‘26 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Raghuram Selvaraju
67% 1-yr VNDA win rate
23 Feb ‘26 1 month ago